Search research articles
Contact Us
Filters
Showing results (1-10 of 234) with videos related to
Page
of 24
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 31, 2003
Safety in iron management
Steven Fishbane
Seminars in Dialysis
|
February 6, 2008
Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines
Steven Fishbane
Blood Purification
|
December 16, 2006
What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease
Steven Fishbane
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 28, 2006
EPO adjuvant treatments: a need for more evidence
Steven Fishbane
The Physician and Sportsmedicine
|
December 22, 2017
Exercise-Induced Renal and Electrolyte Changes
Steven Fishbane
Kidney International
|
September 27, 2008
Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective
Steven Fishbane
Journal of the American Society of Nephrology : JASN
|
March 18, 2005
Cardiovascular risk evaluation before kidney transplantation
Steven Fishbane
Seminars in Nephrology
|
May 29, 2016
Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease
Steven Fishbane
Seminars in Dialysis
|
October 1, 2016
What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: The Role for Newly Approved Iron Treatments
Steven Fishbane
Heart Failure Clinics
|
September 2, 2008
Anemia and cardiovascular risk in the patient with kidney disease
Steven Fishbane
Page
of 24
Search research articles
Search
Showing results (1-10 of 234) with videos related to
Sort By:
Page
of 24
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 31, 2003
Safety in iron management
Steven Fishbane
Seminars in Dialysis
|
February 6, 2008
Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines
Steven Fishbane
Blood Purification
|
December 16, 2006
What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease
Steven Fishbane
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 28, 2006
EPO adjuvant treatments: a need for more evidence
Steven Fishbane
The Physician and Sportsmedicine
|
December 22, 2017
Exercise-Induced Renal and Electrolyte Changes
Steven Fishbane
Kidney International
|
September 27, 2008
Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective
Steven Fishbane
Journal of the American Society of Nephrology : JASN
|
March 18, 2005
Cardiovascular risk evaluation before kidney transplantation
Steven Fishbane
Seminars in Nephrology
|
May 29, 2016
Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease
Steven Fishbane
Seminars in Dialysis
|
October 1, 2016
What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: The Role for Newly Approved Iron Treatments
Steven Fishbane
Heart Failure Clinics
|
September 2, 2008
Anemia and cardiovascular risk in the patient with kidney disease
Steven Fishbane
Page
of 24